In this case series, Burdier and colleagues describe the contrasting progress of cervical cancer screening programmes in Bhutan, India, and Türkiye, drawing on presentations from the CHIC South Asia Symposium (New Delhi, 2022). India, despite national VIA-based guidelines since 2016, reports only 1.9% ever-screened coverage among women aged 30–49, constrained by infrastructure gaps and absent […]
Topic: Screening Implementation Experience
Lessons learned from cervical cancer screening program: ROSE program – Malaysia
The ROSE program (Removing Obstacles to Cervical Screening) in Malaysia addresses persistently low Pap smear uptake despite decades of free screening. It introduces self-sampling HPV testing, laboratory processing, and mobile-based results to improve convenience and privacy. Barriers identified include stigma, limited awareness, poor clinic environments, and fragmented health sectors. Community engagement leverages local champions, religious […]
Cervical Cancer Screening Implementation in Turkey
Turkey transitioned in 2014 from Pap smear–based cervical cancer screening to a national HPV DNA–based program targeting women ≥30 years every five years. Dual sampling (HPV DNA plus reflex Pap smear) is analyzed centrally in a high-throughput mega-laboratory with real-time digital tracking and mobile result delivery. This centralized model increased screening coverage from
Cervical Cancer Screening Landscape – Q&A Session
The Q&A session focused on Turkey’s centralized HPV screening program and its cost-effectiveness. Dr. Gultekin explained that initial large tenders and early adoption allowed screening costs to drop below USD 5 per woman, with new validated national kits expected to reduce this further to under USD 1. Questions addressed management of equivocal results (retesting is […]